SFM
VNDA icon

Systematic Financial Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Systematic Financial Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-29,640
Closed -$339K – 449
2020
Q2 		$339K Sell
29,640
-9,120
-24% -$103K 0.02% 231
2020
Q1 		$402K Buy
38,760
+3,055
+9% +$37.9K 0.02% 220
2019
Q4 		$586K Sell
35,705
-6,590
-16% -$99.6K 0.02% 373
2019
Q3 		$562K Sell
42,295
-24,520
-37% -$342K 0.03% 291
2019
Q2 		$941K Buy
+66,815
New +$1.06M 0.04% 327
2017
Q1 		– Sell
-119,380
Closed -$1.9M – 698
2016
Q4 		$1.9M Sell
119,380
-825
-0.7% -$13.3K 0.03% 373
2016
Q3 		$2M Buy
+120,205
New +$1.62M 0.03% 330

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Systematic Financial Management's VNDA Position: Q3 2020 in Review

Systematic Financial Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2020, closing a stake of 29,640 shares — an estimated $339K sold.

Systematic Financial Management first reported a position in VNDA in Q3 2016 and held it in 7 quarters. The position peaked at $2M in Q3 2016. 164 funds tracked by Wall St. Rank hold VNDA as of Q3 2020.

  • Systematic Financial Management reported no remaining Vanda Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 29,640 Vanda Pharmaceuticals shares in Q3 2020, an estimated $339K.
  • Systematic Financial Management first reported a position in Vanda Pharmaceuticals in Q3 2016 and held it in 7 quarters.
  • Systematic Financial Management's Vanda Pharmaceuticals position peaked at $2M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.